Pallav S. Shah, Ph.D., MSc, B. Pharm, AMRSC, Director Regulatory Affairs – Europe  at Aspargo Labs, is a pharmaceutical executive with expertise in regulatory affairs, pharmacovigilance, and medicinal chemistry. With a strong foundation in life sciences and regulatory compliance, Dr. Shah has led initiatives supporting global pharmaceutical companies in licensing, dossier submissions, and risk management.

Prior to his current role, Dr. Shah served as Chief Executive of Cambridge Regulatory Services, where he was responsible for overseeing regulatory strategy, pharmacovigilance operations, and medical information services. He managed marketing authorization applications, clinical trial applications, risk-benefit assessments, and ensured adherence to international regulatory standards.

Dr. Shah holds a Ph.D. in Medicinal Chemistry from the University of the West of Scotland, where his research focused on the synthesis and evaluation of novel compounds for the treatment of hormone-dependent breast cancer. He also earned an MSc in Pharmaceutical Science from Kingston University and a B. Pharm in Pharmaceutical Science from Mumbai University.